Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry Ulrike.

Slides:

Advertisements

Similar presentations

Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab Chad J. Hruska, MD, Robert J. Bertoli, MD, Yorke D. Young, MD, Patrick.

Advertisements

Surgical margins for melanoma in situ

Optimal time to provide skin cancer and photoprotection education to pediatric solid organ transplant recipients Lily Chen, BA, Feng Gao, MD, PhD, MPH,

Periungual fibroma (Koenen tumors) as isolated sign of tuberous sclerosis complex with tuberous sclerosis complex 1 germline mutation Sven R. Quist,

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Lauren Kwa, BA, Jonathan I. Silverberg, MD, PhD, MPH

A girl with a solitary red bulla

Yul W. Yang, MD, PhD, David J. DiCaudo, MD

Daniel S. Winchester, MD, Thomas L. Hocker, MD, Randall K. Roenigk, MD

Image registration of sequential transparent photographs to localize and detect new versus recurrent tumors in dermatologic and Mohs micrographic surgery

Baldness reversed by chemotherapy

Megan Wood, MD, Tom Raisanen, MD, Ingrid Polcari, MD

Array of cutaneous adverse effects associated with sorafenib

Elana Putterman, BS, Leslie Castelo-Soccio, MD, PhD

The impact of secukinumab treatment on the prevalence of human papillomavirus in patients with psoriasis: A pilot study Hsien-Yi Chiu, MD, Tsen-Fang.

Pediatric teledermatology: Observations based on 429 consults

Melanoma survival in the United States, 1992 to 2005

Sue-Min Lai, PhD, MS, MBA, Jessica B

JAK inhibitors in dermatology: The promise of a new drug class

Sara A. Farber, BA, Sara Samimi, MD, Misha Rosenbach, MD

Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center Laura Kooistra, BS, Claudia Ricotti, BS, Fabrizio.

Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: A randomized controlled trial William Tuong,

Pharmacy costs of specialty medications for plaque psoriasis in the United States Eric J. Yang, BS, Kristen M. Beck, MD, Sahil Sekhon, MD, Tina Bhutani,

Smoking and risk of psoriasis: A nationwide cohort study

Methotrexate treatment in patients with a history of cutaneous melanoma and the risk of a consecutive primary melanoma: A national retrospective registry-based.

Pilot study of a skin cancer education curriculum for medical students

Applying for dermatology residency is difficult and expensive

Heterogeneous spectrum of acral melanoma: A clinicoprognostic study of 213 acral melanomas according to tumor site Hye Rim Moon, MD, Hyun Ji Kang, MD,

Toxic epidermal necrolysis secondary to emergency contraceptive pills

Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study Thomas K. Eigentler, Ulrike Leiter, Hans-Martin Häfner,

Chauncey C. Caldwell, MD, Sami K. Saikaly, MD, Robert P

Reply to: “A note on normality”

The applicability and prognostic value of the TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome.

Successful use of a modified Goeckerman regimen in the treatment of generalized prurigo nodularis Eric Sorenson, AB, Ethan Levin, MD, John Koo, MD, Timothy.

A survey-based study on nail examinations at an American Academy of Dermatology free skin cancer screening Dayoung Ko, BS, Shari R. Lipner, MD, PhD

Infectious rash after riding elephants

Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases Alan S. Boyd, MD, Bashar Shakhtour,

Lip edema Journal of the American Academy of Dermatology

Adult-onset multiple myofibromas

Isotretinoin for high-grade or refractory epidermal growth factor receptor inhibitor-related acneiform papulopustular eruptions Herbert C. Chiang, MD,

Pooja H. Rambhia, BA, Ivan J. Stojanov, DMD, Joshua Arbesman, MD

Hugh Gloster, MD, Chesahna Kindred, MBA

Seasonal patterns in alopecia areata, totalis, and universalis

Medicaid acceptance among pediatric dermatologists

Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma.

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients? Michael A. Marchetti, MD, Edmund K. Bartlett,

Penile calciphylaxis Journal of the American Academy of Dermatology

Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes.

Recent dermatology visit is associated with thinner Breslow depth nodular melanomas Erin X. Wei, MD, Lucy Chen, MD, Fangchao Ma, PhD, Jonette Keri, MD,

Christopher T. Cassetty, MD, Andrew F. Alexis, MD, MPH, Jerome L

Tsung-Yu Tsai, MD, Yu-Chen Huang, MD

Modification of the nail psoriasis severity index

Tofacitinib therapy for children with severe alopecia areata

Gordon W. Jung, MD, Patricia T. Ting, MSc, MD, Thomas G

Jose Fernández-Vozmediano, PhD, Jose Armario-Hita, MD

Michelle A. Pipitone, MD, Brian Adams, MD, MPH, Anita Sheth, MD, T

Digital photography in the diagnosis of scabies

Dermatomyositis associated with malignant melanoma—A marker of poor prognosis? Meinhard Schiller, MD, Markus Böhm, MD, Peter Hensen, MD, Helge Riemann,

Descriptive survival study of nail melanoma patients treated with functional surgery versus distal amputation Suelen Montagner, MD, Francisco Aparecido.

A simple algorithm for evaluating dermatologic disease in critically ill patients: A study based on retrospective review of medical intensive care unit.

Eyebrow transplantation: Alternative body sites as a donor source

Recurrence of nevus depigmentosus after an autologous epidermal graft

Gaps in pain management in dermatology: A needs assessment from Canada

Numerous hyperpigmented macules of the oral mucosa

Brittany G. Craiglow, MD, Brett A. King, MD, PhD

Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia Jacob J. Inda, MD, Brian F. Kabat,

Randomized study of topical tacrolimus ointment as possible treatment for resistant idiopathic pruritus ani Erwin Suys, MD Journal of the American Academy.

“Boot foot” with pseudomonas colonization

Orit Kaidar-Person, MD, Ayelet Eran, MD, Gil Bar-Sela, MD

Stuart M. Goldsmith, MD, Armand B. Cognetta, MD

Presentation transcript:

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry Ulrike Leiter, MD, Petra G. Buettner, PhD, Thomas K. Eigentler, MD, Eva B. Bröcker, MD, Christiane Voit, MD, Harald Gollnick, MD, Wolfgang Marsch, MD, Uwe Wollina, MD, Friedegund Meier, MD, Claus Garbe, MD Journal of the American Academy of Dermatology Volume 66, Issue 1, Pages 37-45 (January 2012) DOI: 10.1016/j.jaad.2010.09.772 Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 A, Probability of recurrence-free survival after primary cutaneous melanoma (CM) diagnosis according to stages. B, Probability of secondary melanoma–free survival after primary CM diagnosis. Journal of the American Academy of Dermatology 2012 66, 37-45DOI: (10.1016/j.jaad.2010.09.772) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Hazard rates (per person-year) for recurrences according to stages (A); for recurrences according to stages IA and IB (B); and for secondary melanoma (C). Journal of the American Academy of Dermatology 2012 66, 37-45DOI: (10.1016/j.jaad.2010.09.772) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions

Fig 3 Cumulative hazard function (per person-year) for secondary melanoma. Journal of the American Academy of Dermatology 2012 66, 37-45DOI: (10.1016/j.jaad.2010.09.772) Copyright © 2010 American Academy of Dermatology, Inc. Terms and Conditions